[go: up one dir, main page]

SE8300495L - Forbettringar av eller i samband med nasala farmaceutiska kompositioner - Google Patents

Forbettringar av eller i samband med nasala farmaceutiska kompositioner

Info

Publication number
SE8300495L
SE8300495L SE8300495A SE8300495A SE8300495L SE 8300495 L SE8300495 L SE 8300495L SE 8300495 A SE8300495 A SE 8300495A SE 8300495 A SE8300495 A SE 8300495A SE 8300495 L SE8300495 L SE 8300495L
Authority
SE
Sweden
Prior art keywords
connection
pharmaceutical compositions
nasal pharmaceutical
ciliary function
nasal
Prior art date
Application number
SE8300495A
Other languages
English (en)
Other versions
SE8300495D0 (sv
SE454402B (sv
Inventor
J-R Kiechel
F Acezat-Mispelter
D Plas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8300495D0 publication Critical patent/SE8300495D0/sv
Publication of SE8300495L publication Critical patent/SE8300495L/sv
Publication of SE454402B publication Critical patent/SE454402B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8300495A 1982-02-01 1983-01-31 Nasalt administrerbar farmaceutisk komposition innehallande en ergotpeptidalkaloid samt ett xantin SE454402B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
SE8300495D0 SE8300495D0 (sv) 1983-01-31
SE8300495L true SE8300495L (sv) 1983-08-02
SE454402B SE454402B (sv) 1988-05-02

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300495A SE454402B (sv) 1982-02-01 1983-01-31 Nasalt administrerbar farmaceutisk komposition innehallande en ergotpeptidalkaloid samt ett xantin

Country Status (27)

Country Link
JP (1) JPS58134017A (sv)
AT (1) AT385656B (sv)
AU (1) AU565613B2 (sv)
BE (1) BE895750A (sv)
CA (1) CA1197783A (sv)
CH (1) CH653555A5 (sv)
DE (1) DE3302949A1 (sv)
DK (1) DK164771C (sv)
ES (1) ES8502865A1 (sv)
FI (1) FI81258C (sv)
FR (1) FR2539994B1 (sv)
GR (1) GR81320B (sv)
HK (1) HK59989A (sv)
HU (1) HU191512B (sv)
IE (1) IE54532B1 (sv)
IL (1) IL67822A (sv)
IT (1) IT1197558B (sv)
KE (1) KE3888A (sv)
LU (1) LU84613A1 (sv)
MY (1) MY8700766A (sv)
NL (1) NL192325C (sv)
NZ (1) NZ203117A (sv)
PH (1) PH22198A (sv)
PT (1) PT76166B (sv)
SE (1) SE454402B (sv)
SG (1) SG34389G (sv)
ZA (1) ZA83673B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
ES2937440T3 (es) * 2018-01-05 2023-03-28 Impel Pharmaceuticals Inc Administración intranasal de dihidroergotamina mediante un dispositivo olfativo de precisión

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IT8347646A0 (it) 1983-02-01
DE3302949A1 (de) 1983-08-11
IL67822A (en) 1988-02-29
HK59989A (en) 1989-08-04
SE8300495D0 (sv) 1983-01-31
IT1197558B (it) 1988-12-06
PT76166B (en) 1986-02-04
MY8700766A (en) 1987-12-31
JPS58134017A (ja) 1983-08-10
HU191512B (en) 1987-02-27
DE3302949C2 (sv) 1992-05-21
IL67822A0 (en) 1983-06-15
PH22198A (en) 1988-06-28
GR81320B (sv) 1984-12-11
DK38183D0 (da) 1983-01-31
AU1085083A (en) 1983-08-11
NZ203117A (en) 1986-12-05
IE830187L (en) 1983-08-01
ATA30383A (de) 1987-10-15
SG34389G (en) 1989-09-22
FI81258C (sv) 1990-10-10
CH653555A5 (de) 1986-01-15
NL192325B (nl) 1997-02-03
BE895750A (fr) 1983-08-01
DK38183A (da) 1983-08-02
KE3888A (en) 1989-09-01
FI81258B (fi) 1990-06-29
ZA83673B (en) 1984-09-26
DK164771B (da) 1992-08-17
CA1197783A (en) 1985-12-10
DK164771C (da) 1992-12-28
IT8347646A1 (it) 1984-08-01
IE54532B1 (en) 1989-11-08
NL192325C (nl) 1997-06-04
FI830245L (fi) 1983-08-02
PT76166A (en) 1983-02-01
FR2539994B1 (fr) 1986-10-10
JPH0253406B2 (sv) 1990-11-16
ES519450A0 (es) 1985-02-01
ES8502865A1 (es) 1985-02-01
AT385656B (de) 1988-05-10
LU84613A1 (fr) 1983-09-08
SE454402B (sv) 1988-05-02
NL8300325A (nl) 1983-09-01
FR2539994A1 (fr) 1984-08-03
AU565613B2 (en) 1987-09-24
FI830245A0 (fi) 1983-01-25

Similar Documents

Publication Publication Date Title
DE3484997D1 (de) Zellstimulierendes mittel.
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
NZ195517A (en) Imidazole-5-acetic acid derivatives and pharmaceutical compositions
CA2090422A1 (en) Pharmaceutical composition of florfenicol
MY101791A (en) New benzimidazole derivatives
SE441179B (sv) Nya cyklopropankarboxylsyror med polyhalogenerad substituent, sett for framstellning derav samt anvendning derav i pesticidkompositioner
DE3872635D1 (de) Pentamidin enthaltende pharmazeutische zusammensetzungen.
IT8468241A0 (it) Derivati del triptofano farmaceuti camente attivi e composizioni farmaceutiche che li contengono
EP0173092A3 (en) Anti viral composition
IT8348747A0 (it) Derivati amminometil-benzenici eteroaril-sostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni farmaceutiche che li contengono
IE781032L (en) Pharmaceutical compositions
ZA812088B (en) Derivative of saccharide and physiologically active agent containing the same
SE8504976L (sv) Ogondroppar innehallande bromocriptin
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
IT1207504B (it) Composizione moderatrice dell'appetito ed antigastrica.
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
NZ184766A (en) Alkylphenyl ethers and thioethers and pharmaceutical compositions
SE8300495L (sv) Forbettringar av eller i samband med nasala farmaceutiska kompositioner
ZA773979B (en) Pharmaceutically active benzamine compounds and compositions
NZ191006A (en) Pyrimidine derivatives of isoureas and isothioureas pharmaceutical compositions
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
IE44590L (en) Coccidiocidal composition
GB2037289B (en) Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8300495-2

Format of ref document f/p: F

NUG Patent has lapsed